A Study Of Hypotension In Critically Ill Patients Undergoing CRRT With Mean Systemic Filling Pressure

Overview

About this study

The purpose of this study is to evaluate the effectiveness of MSFParm in predicting hypotension associated with volume removal during treatment with continuous renal replacement therapy (CRRT), with a lead time of at least 15-30 minutes.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Non-incarcerated adult patients (≥18 years) admitted to an ICU.

  • Presence of a distal upper extremity arterial line (i.e., radial, ulnar, brachial)

  • Undergoing CRRT for at least 6 hours.

Exclusion Criteria:

  • Patients receiving ECMO or other mechanical circulatory support.

  • Patients with an arterial line malfunction.

  • Patients with extremity ischemia due to arteriopathies

  • Patients for whom a blood pressure cuff cannot be used on the arm, such as those with a history of lymphatic surgery or other conditions affecting the upper extremity.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 8/20/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Kianoush Banaei Kashani

Open for enrollment

Contact information:

Kianoush Banaei Kashani

(507) 538-7293

kashani.kianoush@mayo.edu

More information

Publications

Publications are currently not available